Randolph Sophia's Form 4 filing
Alx Oncology Holdings Inc (ALXO) · filed May 15, 2024
- Accession no.
- 0001415889-24-013237
- Filed
- May 15, 2024
- Trade date
- May 13, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $191.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Randolph SophiaCIK 0001817127 | Director, Officer (CHIEF MEDICAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 13, 2024 | Common Stock | SSaleDisposed | −10,203 | $15.82 | −$161,411.46 | 332,146 | Direct | |
| May 13, 2024 | Common Stock | SSaleDisposed | −1,797 | $16.67 | −$29,955.99 | 330,349 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.